Aerie Pharmaceuticals Inc
AERIDelisted Nov 21, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001337553
Aerie Pharmaceuticals Inc was delisted on Nov 21, 2022; its insiders filed their last Form 4 on Nov 21, 2022; 156 institutions reported holding it in 13F filings for Q3 2022, worth $710.6M in total; no superinvestor held it.
Holders of 5% or more of AERI
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Aerie Pharmaceuticals Inc, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Aerie Pharmaceuticals Inc on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
9 Schedule 13D and 13G filings on Aerie Pharmaceuticals Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 14, 2022 | PFM Health Sciences, LP | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Flynn James E | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2022 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2022 | Morgan Stanley | 13GOld format | – | New | – | SEC |
| Aug 16, 2021 | Flynn James E | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | PFM Health Sciences, LP | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2021 | Hartford Mutual Funds Inc | 13GOld format | – | New | – | SEC |
| Feb 5, 20217:51 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Aerie Pharmaceuticals Inc shares.
No Form 144 notices for Aerie Pharmaceuticals Inc are on file.